Hen Chaushu

Hen Chaushu

Auto-generated profile, based on publicly available information

Hen Chaushu

Department of Otolaryngology‐Head and Neck Surgery and Maxillofacial Surgery Tel Aviv Sourasky Medical Center Tel Aviv Israel

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2023 in Clinical Otolaryngology
Verified
Journal Article
Closed access
HCHen Chaushu
Hen Chaushu
OUOmer J. Ungar
Omer J. Ungar
RERani Abu Eta
Rani Abu Eta
OHOphir Handzel
Ophir Handzel
NMNidal Muhanna
Nidal Muhanna
YOYahav Oron
Yahav Oron

20 September 2024 in The Laryngoscope
Verified
Journal Article
Open access
LKLinor Klein
Linor Klein
RVRoni Vass
Roni Vass
YOYahav Oron
Yahav Oron
RARani Abu‐Eta
Rani Abu‐Eta
SSShahaf Shilo
Shahaf Shilo
OUOmer J. Ungar
Omer J. Ungar
Objective: To study predictors of delayed presentation, diagnosis, and treatment of idiopathic sudden sensorineural hearing loss (ISSNHL).Study Design: Retrospective medical chart review and patient telephone survey.Setting: Tertiary medical center.Subjects and Methods: All patients who initially presented or referred with unilateral ISSNHL between 2016 and 2020 were included. Associations between epidemiological, demographic, and socioeconomic profiles and delays in presentation, diagnosis and treatment were studied.Results: A total of 518 patients were suitable for study inclusion. The total delay in the emergency department (ED) setup was a median (interquartile range, IQR) of 1 (0–1) day, 7 (6–12) days in a community otolaryngologist setup, and 15 (8–25) days in a general practitioner setup. Patients who presented to the ED first also had fewer diagnostic and treatment delays. Those who presented to a community otolaryngologist first had significantly longer presentation delay (5 [4–8] days p < 0.001) and significantly longer treatment delays (1 [1–3] days p < 0.001). Patients who presented to a general practitioner first had significantly longer presentation delays compared with ED presentation, and the longest diagnostic and treatment delays (3 [2–5], 8 [4–12] days, and 4 [2–7] days, p = < 0.01, p = <0.01, and p < 0.001, respectively). There was no association between socioeconomic status or demography and presentation, diagnostic, or treatment delays.Conclusion: Total delay in ISSNHL management is affected by the venue of the first medical encounter. General practitioners' level of awareness of the need for empiric steroidal treatment of ISSNHL without delay should be raised.Level of Evidence: 3 Laryngoscope, 135:889–893, 2025

27 September 2025 in World Journal of Otorhinolaryngology - Head and Neck Surgery
Verified
Journal Article
Open access
HCHen Chaushu
Hen Chaushu
NNNarin Nard Carmel Neiderman
Narin Nard Carmel Neiderman
YPYuval Presman
Yuval Presman
ADAlexandra Dorman
Alexandra Dorman
RVRoni Vass
Roni Vass
AAAvraham Abergel
Avraham Abergel
Purpose: The rising prevalence of obesity introduces challenges in surgical contexts, including endoscopic sinus surgery (ESS) for chronic rhinosinusitis with nasal polyps (CRSwNP). However, the impact of obesity on ESS outcomes remains underexplored. This study aims to evaluate the association between obesity and surgical complexity, operative duration, postoperative quality of life (QOL), in patients with CRSwNP undergoing ESS.Methods: A retrospective analysis was conducted on 310 adult patients who underwent ESS for CRSwNP at a tertiary medical center between 2013 and 2023. Patients were categorized into two groups: Nonobese (BMI < 30 kg/m²) and obese (BMI ≥ 30 kg/m²). Outcomes assessed included operative time, postoperative complications, and QOL using the Sinonasal Outcome Test (SNOT‐22).Results: Of the 310 patients, 62 (20%) were obese. Obese patients had significantly higher preoperative Lund–Mackay scores (18.5 ± 4.7 vs. 16 ± 5.5, p = 0.036), longer operative durations (179 ± 61 vs. 162 ± 59 min, p = 0.034), and worse postoperative SNOT‐22 scores (38 ± 26 vs. 24 ± 22, p = 0.041) compared to nonobese patients. However, only six obese patients completed paired pre‐ and postoperative snot‐22 data. They were also more likely to require prolonged oral steroid use (> 3 months) (37% vs. 21%, p = 0.013) and biological treatments (21% vs. 8%, p = 0.01). No significant differences were observed in immediate postoperative complications or hospital stays.Conclusion: Obesity was not associated with increased surgical risk or delayed recovery following ESS for CRSwNP. However, obese patients had more severe disease and achieved less symptom improvement, highlighting the need for tailored postoperative care and adjunct therapies to optimize outcomes.

6 July 2026 in International Forum of Allergy & Rhinology
Verified
Journal Article
Open access
PDF file
TFTom Fischer
Tom Fischer
KAKeren Avirame
Keren Avirame
IPIdan Peled
Idan Peled
EHElla Hazan
Ella Hazan
EHElinoy Herstain
Elinoy Herstain
Narin Carmel NeidermanNarin Carmel Neiderman
Narin Carmel Neiderman
Key Points: The emotional burden of olfactory dysfunction bears distinct psychological profiles. Objective olfactory dysfunction findings do not reliably reflect patients' emotional burden. Olfactory‐related quality of life assessment may identify patient risk of emotional distress.

16 July 2026 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
EAElay Amidor
Elay Amidor
NMNidal Muhanna
Nidal Muhanna
AAAvraham Abergel
Avraham Abergel
Narin Carmel NeidermanNarin Carmel Neiderman
Narin Carmel Neiderman
DRDavid Rosen
David Rosen
HCHen Chaushu
Hen Chaushu

30 July 2026 in American Journal of Rhinology & Allergy
Verified
Journal Article
Open access
HCHen Chaushu
Hen Chaushu
RBRan Bilaus
Ran Bilaus
Narin Carmel NeidermanNarin Carmel Neiderman
Narin Carmel Neiderman
AAAvraham Abergel
Avraham Abergel
TPTimur Pestrikov
Timur Pestrikov
FJForsan Jahshan
Forsan Jahshan
Background: Recurrent acute rhinosinusitis (RARS) is traditionally regarded as an episodic infectious disorder with complete mucosal recovery between attacks. However, histopathological evidence supporting this assumption is limited. Objective: To evaluate whether mucosal inflammatory and remodeling changes persist during the asymptomatic interval in patients with RARS compared with nonsinusitis surgical controls. Methods: In this prospective observational study (January 2023–December 2025), sinonasal mucosal specimens obtained during functional endoscopic sinus surgery were analyzed from adults with RARS and nonsinusitis surgical controls. Patients with chronic rhinosinusitis, active infection, or recent systemic corticosteroid use were excluded. Histopathological outcomes included neovascularization, submucosal fibrosis, inflammatory infiltration, and basement membrane thickness. Results: Twenty-four patients were included (17 RARS; 7 controls). Compared with controls, RARS specimens demonstrated higher neovascularization scores (median 2.0 vs 1.0; median difference, 1.0; 95% CI, 0.2-1.8; P = .034) and greater submucosal fibrosis (median 2.0 vs 1.0; median difference, 1.0; 95% CI, 0.1-1.9; P = .047). Inflammatory infiltration was numerically higher but did not reach statistical significance (median difference, 0.5; 95% CI, −0.1 to 1.1; P = .053); severe inflammation was observed only in RARS specimens (35% vs 0%). Basement membrane thickness did not differ between groups. Higher symptom burden (SNOT-22 ≥ 57.5) was associated with greater fibrosis ( P = .041). Conclusion: In this surgically treated cohort, RARS was associated with persistent mucosal neovascularization and fibrosis despite clinical quiescence. These findings suggest that RARS may involve ongoing interepisode tissue remodeling rather than a purely episodic process.